< Back to previous page
Researcher
Asmin Andries
- Disciplines:Analytical chemistry, Biomarker discovery and evaluation, Drug discovery and development, Pharmaceutical analysis and quality assurance, Other pharmaceutical sciences
Affiliations
- Pharmaceutical Analysis (Division)
Member
From1 Sep 2016 → 30 Sep 2021
Projects
1 - 1 of 1
- Research into biomarkers for early detection of Autosomal Dominant Polycystic Kidney DiseaseFrom1 Oct 2016 → 2 Sep 2021Funding: BOF - Doctoral projects, BOF - doctoral mandates
Publications
1 - 6 of 6
- Quantification of allantoin and other metabolites of the purine degradation pathway in human plasma samples using a newly developed HILIC-LC-MS/MS method(2022)
Authors: Asmin Andries, Djalila Mekahli, Ann Van Schepdael
Pages: 1010 - 1018 - Research into biomarkers for early detection of Autosomal Dominant Polycystic Kidney Disease(2021)
Authors: Asmin Andries, Ann Van Schepdael, Djalila Mekahli
- Recent progress in the LC-MS/MS analysis of oxidative stress biomarkers(2021)
Authors: Asmin Andries, Jef Rozenski, Pieter Vermeersch, Djalila Mekahli, Ann Van Schepdael
Pages: 402 - 428 - Oxidative stress in chronic kidney disease(2019)
Authors: Asmin Andries, Djalila Mekahli, Ann Van Schepdael, Bert Bammens
Pages: 975 - 991 - Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?(2019)
Authors: Asmin Andries, Bert Bammens, Djalila Mekahli, Ann Van Schepdael
Pages: 993 - 1008 - Simultaneous determination of allantoin and adenosine in human urine using liquid chromatography - UV detection(2018)
Authors: Asmin Andries, Stéphanie De Rechter, Djalila Mekahli, Ann Van Schepdael
Pages: 201 - 207